200 related articles for article (PubMed ID: 28872486)
21. Optimal Serum Ferritin Levels for Iron Deficiency Anemia during Oral Iron Therapy (OIT) in Japanese Hemodialysis Patients with Minor Inflammation and Benefit of Intravenous Iron Therapy for OIT-Nonresponders.
Takasawa K; Takaeda C; Wada T; Ueda N
Nutrients; 2018 Mar; 10(4):. PubMed ID: 29596361
[No Abstract] [Full Text] [Related]
22. Comparison of the Therapeutic Effects and Side Effects of Oral Iron Supplements in Iron Deficiency Anemia.
Wu TW; Tsai FP
Drug Res (Stuttg); 2016 May; 66(5):257-61. PubMed ID: 26697889
[TBL] [Abstract][Full Text] [Related]
23. Iron(III)-hydroxide polymaltose complex in iron deficiency anemia / review and meta-analysis.
Toblli JE; Brignoli R
Arzneimittelforschung; 2007; 57(6A):431-8. PubMed ID: 17691593
[TBL] [Abstract][Full Text] [Related]
24. Preventive intervention for iron deficiency anaemia in a high risk population.
Jaber L
Int J Risk Saf Med; 2014; 26(3):155-62. PubMed ID: 25214161
[TBL] [Abstract][Full Text] [Related]
25. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.
Van Wyck DB; Mangione A; Morrison J; Hadley PE; Jehle JA; Goodnough LT
Transfusion; 2009 Dec; 49(12):2719-28. PubMed ID: 19682342
[TBL] [Abstract][Full Text] [Related]
26. A comparison between intravenous iron polymaltose complex (Ferrum Hausmann) and oral ferrous fumarate in the treatment of iron deficiency anaemia in pregnancy.
Singh K; Fong YF; Kuperan P
Eur J Haematol; 1998 Feb; 60(2):119-24. PubMed ID: 9508353
[TBL] [Abstract][Full Text] [Related]
27. Ferrous bisglycinate 25 mg iron is as effective as ferrous sulfate 50 mg iron in the prophylaxis of iron deficiency and anemia during pregnancy in a randomized trial.
Milman N; Jønsson L; Dyre P; Pedersen PL; Larsen LG
J Perinat Med; 2014 Mar; 42(2):197-206. PubMed ID: 24152889
[TBL] [Abstract][Full Text] [Related]
28. Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy. A randomized controlled trial.
Bhavi SB; Jaju PB
BMC Pregnancy Childbirth; 2017 May; 17(1):137. PubMed ID: 28482869
[TBL] [Abstract][Full Text] [Related]
29. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
Schröder O; Mickisch O; Seidler U; de Weerth A; Dignass AU; Herfarth H; Reinshagen M; Schreiber S; Junge U; Schrott M; Stein J
Am J Gastroenterol; 2005 Nov; 100(11):2503-9. PubMed ID: 16279906
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Therapeutic Efficacy of Ferrous Ascorbate and Iron Polymaltose Complex in Iron Deficiency Anemia in Children: A Randomized Controlled Trial.
Patil P; Geevarghese P; Khaire P; Joshi T; Suryawanshi A; Mundada S; Pawar S; Farookh A
Indian J Pediatr; 2019 Dec; 86(12):1112-1117. PubMed ID: 31520309
[TBL] [Abstract][Full Text] [Related]
31. Body iron and individual iron prophylaxis in pregnancy--should the iron dose be adjusted according to serum ferritin?
Milman N; Byg KE; Bergholt T; Eriksen L; Hvas AM
Ann Hematol; 2006 Sep; 85(9):567-73. PubMed ID: 16733739
[TBL] [Abstract][Full Text] [Related]
32. Comparison of efficacy, tolerability, and cost of iron polymaltose complex with ferrous sulphate in the treatment of iron deficiency anemia in pregnant women.
Saha L; Pandhi P; Gopalan S; Malhotra S; Saha PK
MedGenMed; 2007 Jan; 9(1):1. PubMed ID: 17435611
[TBL] [Abstract][Full Text] [Related]
33. Effects of a Tripeptide Iron on Iron-Deficiency Anemia in Rats.
Xiao C; Lei X; Wang Q; Du Z; Jiang L; Chen S; Zhang M; Zhang H; Ren F
Biol Trace Elem Res; 2016 Feb; 169(2):211-7. PubMed ID: 26109335
[TBL] [Abstract][Full Text] [Related]
34. Effect of twice weekly versus daily iron treatment in Turkish children with iron deficiency anemia.
Tavil B; Sipahi T; Gökçe H; Akar N
Pediatr Hematol Oncol; 2003 Jun; 20(4):319-26. PubMed ID: 12746164
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of fortification of corn flour-derived products with hydrogen-reduced elemental iron on iron-deficiency anaemia in children and adolescents in southern Brazil.
Miglioranza LH; Breganó JW; Dichi I; Matsuo T; Dichi JB; Barbosa DS
Public Health Nutr; 2009 Feb; 12(2):244-8. PubMed ID: 18789173
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean women.
Shim JY; Kim MY; Kim YJ; Lee Y; Lee JJ; Jun JK; Shin JC; Cho YK; Lee KY; Kim A; Song TB
BMC Pregnancy Childbirth; 2018 Aug; 18(1):349. PubMed ID: 30153811
[TBL] [Abstract][Full Text] [Related]
37. Iron supplements reduce the risk of iron deficiency anemia in marginally low birth weight infants.
Berglund S; Westrup B; Domellöf M
Pediatrics; 2010 Oct; 126(4):e874-83. PubMed ID: 20819898
[TBL] [Abstract][Full Text] [Related]
38. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
[TBL] [Abstract][Full Text] [Related]
39. Lactoferrin for iron-deficiency anemia in children with inflammatory bowel disease: a clinical trial.
El Amrousy D; El-Afify D; Elsawy A; Elsheikh M; Donia A; Nassar M
Pediatr Res; 2022 Sep; 92(3):762-766. PubMed ID: 35681097
[TBL] [Abstract][Full Text] [Related]
40. Pharmacodynamics and safety of ferric carboxymaltose: a multiple-dose study in patients with iron-deficiency anaemia secondary to a gastrointestinal disorder.
Geisser P; Rumyantsev V
Arzneimittelforschung; 2010; 60(6a):373-85. PubMed ID: 20648929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
